Reported about 5 hours ago
eToro has made a successful debut on the Nasdaq, opening at $69.69, significantly above its IPO price of $52. Meanwhile, Exelixis shares surged after exceeding first-quarter earnings estimates and raising its yearly revenue forecast. Additionally, Septerna entered a $2.2 billion deal with Novo Nordisk to develop obesity-related medications, which includes over $200 million in initial payments.
Source: YAHOO